• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在新加坡,对于幽门螺杆菌感染,使用质子泵抑制剂、阿莫西林和克拉霉素进行经验性一线三联疗法是否仍有作用?时间趋势分析的结果。

Is there still a role for empiric first-line triple therapy using proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori infection in Singapore? Results of a time trend analysis.

机构信息

Department of Gastroenterology, Changi General Hospital, Singapore.

出版信息

J Dig Dis. 2013 Feb;14(2):100-4. doi: 10.1111/1751-2980.12024.

DOI:10.1111/1751-2980.12024
PMID:23253473
Abstract

OBJECTIVE

This study was aimed to assess whether the efficacy of one-week triple therapy comprising of proton pump inhibitor, amoxicillin and clarithromycin (PPI/A/C) on Helicobacter pylori (H. pylori) infection in Singapore has decreased over the duration from 2005 to 2010.

METHODS

The clinical data of H. pylori-positive patients treated with one-week PPI/A/C in 2005 and 2010 were reviewed retrospectively using a registry database. The primary endpoint was the difference in treatment success rate.

RESULTS

A total of 465 patients (n = 174 in 2005 and n = 291 in 2010) were analyzed. In 2010, compared with 2005, the mean age of patients was younger (47 vs 56 years, P < 0.001) and the proportion of foreigners was higher (19.9% vs 5.7%, P < 0.001). The success rate of H. pylori eradication remained similar over the two time periods (90.2% in 2005 vs 88.7% in 2010, P = 0.597). Multinomial logistic regression revealed that mean age, gender, diagnosis and nationality had no impact on the success of H. pylori eradication.

CONCLUSIONS

From 2005 to 2010, there was no significant decrease in the efficacy of one-week PPI/A/C for the treatment of H. pylori infection. This treatment regime remained an effective first-line therapy for H. pylori infection in Singapore.

摘要

目的

本研究旨在评估质子泵抑制剂、阿莫西林和克拉霉素(PPI/A/C)一周三联疗法治疗新加坡幽门螺杆菌(H. pylori)感染的疗效是否在 2005 年至 2010 年期间有所下降。

方法

回顾性使用登记数据库分析 2005 年和 2010 年接受一周 PPI/A/C 治疗的 H. pylori 阳性患者的临床数据。主要终点是治疗成功率的差异。

结果

共分析了 465 例患者(2005 年 n = 174,2010 年 n = 291)。与 2005 年相比,2010 年患者的平均年龄更年轻(47 岁比 56 岁,P < 0.001),外国人比例更高(19.9%比 5.7%,P < 0.001)。两个时期 H. pylori 根除的成功率相似(2005 年为 90.2%,2010 年为 88.7%,P = 0.597)。多项逻辑回归显示,平均年龄、性别、诊断和国籍对 H. pylori 根除的成功率没有影响。

结论

从 2005 年到 2010 年,PPI/A/C 一周三联疗法治疗 H. pylori 感染的疗效没有显著下降。这种治疗方案仍然是新加坡 H. pylori 感染的有效一线治疗方法。

相似文献

1
Is there still a role for empiric first-line triple therapy using proton pump inhibitor, amoxicillin and clarithromycin for Helicobacter pylori infection in Singapore? Results of a time trend analysis.在新加坡,对于幽门螺杆菌感染,使用质子泵抑制剂、阿莫西林和克拉霉素进行经验性一线三联疗法是否仍有作用?时间趋势分析的结果。
J Dig Dis. 2013 Feb;14(2):100-4. doi: 10.1111/1751-2980.12024.
2
Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection.三种不同质子泵抑制剂联合阿莫西林和甲硝唑用于幽门螺杆菌感染再治疗的评估
J Clin Gastroenterol. 2008 Feb;42(2):139-42. doi: 10.1097/MCG.0b013e31802cbc1a.
3
Efficacy of Helicobacter pylori eradication therapy in chronic liver disease.幽门螺杆菌根除治疗在慢性肝病中的疗效
Dig Liver Dis. 2009 Feb;41(2):134-40. doi: 10.1016/j.dld.2008.03.005. Epub 2008 Apr 23.
4
Efficacy of PPI, levofloxacin and amoxicillin in the eradication of Helicobacter pylori compared to conventional triple therapy at a Venezuelan hospital.在委内瑞拉一家医院,与传统三联疗法相比,质子泵抑制剂、左氧氟沙星和阿莫西林根除幽门螺杆菌的疗效。
Arab J Gastroenterol. 2013 Sep;14(3):123-5. doi: 10.1016/j.ajg.2013.09.001. Epub 2013 Oct 14.
5
Comparative study of Helicobacter pylori eradication rates of twice-versus four-times-daily amoxicillin administered with proton pump inhibitor and clarithromycin: a randomized study.质子泵抑制剂和克拉霉素联合使用时,每日两次与每日四次阿莫西林根除幽门螺杆菌率的比较研究:一项随机研究。
Helicobacter. 2008 Aug;13(4):282-7. doi: 10.1111/j.1523-5378.2008.00615.x.
6
Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough.综述文章:近十年来,标准三联疗法治疗幽门螺杆菌的疗效并未改变,但效果还不够理想。
Aliment Pharmacol Ther. 2011 Dec;34(11-12):1255-68. doi: 10.1111/j.1365-2036.2011.04887.x. Epub 2011 Oct 21.
7
Ten-year trend of the cumulative Helicobacter pylori eradication rate for the 'Japanese eradication strategy'.日本根除策略下 10 年累积幽门螺杆菌根除率的趋势
Digestion. 2013;88(4):272-8. doi: 10.1159/000353313.
8
A retrospective study on efficacy of proton-pump inhibitor-based triple therapy for eradication of Helicobacter pylori in patients with chronic renal failure.一项关于基于质子泵抑制剂的三联疗法根除慢性肾衰竭患者幽门螺杆菌疗效的回顾性研究。
Singapore Med J. 2003 Feb;44(2):74-8.
9
Variables influencing outcome of Helicobacter pylori eradication therapy in South China.影响中国南方幽门螺杆菌根除治疗结局的因素
Helicobacter. 2009 Oct;14(5):91-6. doi: 10.1111/j.1523-5378.2009.00718.x.
10
Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia.序贯疗法与标准三联疗法根除幽门螺杆菌的比较:一项针对非溃疡性消化不良成年患者的14天开放标签随机前瞻性平行组研究。
Clin Ther. 2008 Mar;30(3):528-34. doi: 10.1016/j.clinthera.2008.03.009.

引用本文的文献

1
Treatment Strategies in Singapore.新加坡的治疗策略。
Gut Liver. 2021 Jan 15;15(1):13-18. doi: 10.5009/gnl19308.
2
The Association of Age and Antibiotic Resistance of Helicobacter Pylori: A Study in Jiaxing City, Zhejiang Province, China.幽门螺杆菌的年龄与抗生素耐药性关联:中国浙江省嘉兴市的一项研究
Medicine (Baltimore). 2016 Feb;95(8):e2831. doi: 10.1097/MD.0000000000002831.
3
Comparison of three different regimens against Helicobacter pylori as a first-line treatment: A randomized clinical trial.三种不同治疗方案作为幽门螺杆菌一线治疗的比较:一项随机临床试验。
Bosn J Basic Med Sci. 2016 Jan 1;16(1):52-7. doi: 10.17305/bjbms.2016.660.
4
Current Paradigm and Future Directions for Treatment of Helicobacter pylori Infection.幽门螺杆菌感染治疗的当前范式与未来方向
Curr Treat Options Gastroenterol. 2014 Dec;12(4):373-84. doi: 10.1007/s11938-014-0027-6.
5
Helicobacter pylori research: historical insights and future directions.幽门螺杆菌研究:历史洞察与未来方向。
Nat Rev Gastroenterol Hepatol. 2013 Aug;10(8):495-500. doi: 10.1038/nrgastro.2013.96. Epub 2013 Jun 11.